Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr575 Inhibitors

Olr575 inhibitors are a class of chemical compounds designed to specifically target and inhibit the activity of the Olr575 protein, which is a part of the olfactory receptor family. These inhibitors typically function by binding to the active site of the Olr575 protein, thereby preventing its natural ligand from interacting with the receptor. The olfactory receptor family, to which Olr575 belongs, is a large group of G protein-coupled receptors (GPCRs) involved in the detection of odor molecules. Inhibition of Olr575 can provide valuable insights into the structure-activity relationships and functional mechanisms of olfactory receptors, which are crucial for understanding how organisms perceive and differentiate between a vast array of odors. This class of inhibitors often features diverse structural motifs, including heterocyclic rings and various functional groups, to ensure high affinity and specificity towards Olr575.

The design and synthesis of Olr575 inhibitors involve a combination of computational modeling, medicinal chemistry, and biochemical assays. Computational modeling, such as molecular docking and dynamics simulations, aids in predicting the binding modes and affinity of potential inhibitors to the Olr575 receptor. These predictions are then validated through biochemical assays, where the inhibitory activity of the compounds is quantitatively measured. Additionally, the synthesis of these inhibitors requires precise organic chemistry techniques to create the necessary structural features and functional groups. Through iterative cycles of design, synthesis, and testing, researchers can optimize the inhibitory potency and selectivity of these compounds. Studying Olr575 inhibitors not only enhances the understanding of olfactory receptor biology but also contributes to broader research on GPCRs, which are critical in numerous physiological processes.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

CH5424802

1256580-46-7sc-364461
sc-364461A
5 mg
50 mg
$191.00
$902.00
(0)

ALK inhibitor, potentially affecting proteins in ALK-driven signaling pathways.

Erlotinib, Free Base

183321-74-6sc-396113
sc-396113A
sc-396113B
sc-396113C
sc-396113D
500 mg
1 g
5 g
10 g
100 g
$87.00
$135.00
$293.00
$505.00
$3827.00
42
(0)

Inhibits EGFR tyrosine kinase, potentially affecting proteins in the EGFR signaling pathway.

Ibrutinib

936563-96-1sc-483194
10 mg
$156.00
5
(0)

Inhibits Bruton's tyrosine kinase, potentially affecting proteins in B-cell receptor signaling.

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$26.00
$119.00
$213.00
27
(1)

Inhibits BCR-ABL tyrosine kinase, potentially affecting proteins in leukemia-associated pathways.

Nilotinib

641571-10-0sc-202245
sc-202245A
10 mg
25 mg
$209.00
$413.00
9
(1)

Inhibits BCR-ABL and c-KIT tyrosine kinases, potentially affecting proteins in associated signaling pathways.

Palbociclib

571190-30-2sc-507366
50 mg
$321.00
(0)

Inhibits cyclin-dependent kinases 4 and 6, potentially affecting cell cycle-related proteins.

Pazopanib

444731-52-6sc-396318
sc-396318A
25 mg
50 mg
$130.00
$182.00
2
(1)

Inhibits VEGF receptors, potentially affecting proteins involved in angiogenesis and tumor growth.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

Inhibits multiple kinases, potentially affecting proteins in cell signaling and growth pathways.

ABT-199

1257044-40-8sc-472284
sc-472284A
sc-472284B
sc-472284C
sc-472284D
1 mg
5 mg
10 mg
100 mg
3 g
$118.00
$337.00
$520.00
$832.00
$1632.00
10
(0)

BCL-2 inhibitor, potentially influencing apoptosis-related proteins.